1. Lowe D, John S. Autoimmune hepatitis: Appraisal of current treatment guidelines. World J Hepatol 2018; 10: 911-923.
2.
Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 2018; 66: 345-360.
3.
Eriksen PL, Kreutzfeldt M, Gronbaek H, et al. Enrichment of genetic variants in the glucocorticoid receptor signalling pathway in autoimmune hepatitis with failure of standard treatment. Basic Clin Pharmacol Toxicol 2017; 121: 189-194.
4.
Ferrara G, Petrillo MG, Giani T, et al. Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age. Int J Mol Sci 2019; 20: 444.
5.
Xiao W, Lu MH, Rong PF, et al. 11betahydroxysteroid dehydrogenase1 is associated with the activation of hepatic stellate cells in the development of hepatic fibrosis. Mol Med Rep 2020; 22: 3191-3200.
6.
Gao L, Wang JF, Xiang M, et al. Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure. Dig Dis Sci 2011; 56: 2605-2612.
7.
Rai T, Monoe K, Kanno Y, et al. Expression of human glucocorticoid receptor beta of peripheral blood mononuclear cells in patients with severe autoimmune hepatitis. Fukushima J Med Sci 2006; 52: 65-70.
8.
Rai T, Ohira H, Tojo J, et al. Expression of human glucocorticoid receptor in lymphocytes of patients with autoimmune hepatitis. Hepatol Res 2004; 29: 148-152.
9.
Mack CL, Adams D, Assis DN, et al. (2020): Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology 2020; 72: 671-722.
10.
Miceli DD, Abiuso AMB, Vidal PN, et al. Overexpression of 11beta-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism. Open Vet J 2018; 8: 77-85.
11.
Palmer T, Georgiades I, Treanor D, et al. Improved tissue sections for medical liver biopsies: a comparison of 16 vs 18 g biopsy needles using digital pathology. J Clin Pathol 2014; 67: 415-419.
12.
Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
13.
Cirillo N, Hassona Y, Pignatelli M, et al. Characterization of a novel oral glucocorticoid system and its possible role in disease. J Dent Res 2012; 91: 97-103.
14.
Miceli DD, Abiuso AMB, Vidal PN, et al. Overexpression of 11beta-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism. Open Vet J 2018; 8: 77-85.
15.
Williamson M, Garg R, Wells CM. PlexinB1 promotes nuclear translocation of the glucocorticoid receptor. Cells 2019; 9: 3.
16.
Baker GM, Murphy T, Block T, et al. Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer. Cancer Manag Res 2015; 7: 361-368.
17.
Maggiore G, Nastasio S, Sciveres M. Juvenile autoimmune hepatitis: Spectrum of the disease. World J Hepatol 2014; 6: 464-476.
18.
Sheiko MA, Sundaram SS, Capocelli KE, et al. Outcomes in pediatric autoimmune hepatitis and significance of azathioprine metabolites. J Pediatr Gastroenterol Nutr 2017; 65: 80-85.
19.
Malik N, Venkatesh SK. Imaging of autoimmune hepatitis and overlap syndromes. Abdom Radiol (NY) 2017; 42: 19-27.
20.
Behairy BE, El-Araby HA, Abd El Kader HH, et al. Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis. Ann Hepatol 2016; 15: 682-690.
21.
Quinn MA, McCalla A, He B, et al. Silencing of maternal hepatic glucocorticoid receptor is essential for normal fetal development in mice. Commun Biol 2019; 2: 104.
22.
Eriksen PL, Kreutzfeldt M, Gronbaek H, et al. Enrichment of genetic variants in the glucocorticoid receptor signalling pathway in autoimmune hepatitis with failure of standard treatment. Basic Clin Pharmacol Toxicol 2017; 121: 189-194.
23.
Morgan SA, McCabe EL, Gathercole LL, et al. 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A 2014; 111: E2482-2491.
24.
Konopelska S, Kienitz T, Hughes B, et al. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Clin Endocrinol (Oxf) 2009; 70: 554-560.
25.
Ahmed A, Rabbitt E, Brady T, et al. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. PLoS One 2012; 7: e29531.
26.
Lutz SZ, Peter A, Machicao F, et al. Genetic variation in the 11β-hydroxysteroid-dehydrogenase 1 gene determines NAFLD and visceral obesity. J Clin Endocrinol Metab 2016; 101: 4743-4751.
27.
Zou X, Ramachandran P, Kendall TJ, et al. 11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis. Hepatology 2018; 67: 2167-2181.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
